Comparison of Skin Permeation and Putative Anti-Inflammatory Activity of Commercially Available Topical Products Containing Ibuprofen and Diclofenac

References

• Nair B, Taylor-Gjevre RA. Review of topical diclofenac use in musculoskeletal disease. Pharmaceuticals (Basel). 2010;3(6):1892–1908. doi:10.3390/ph3061892
   Google Scholar
• Gunaydin C, Bilge SS. Effects of nonsteroidal anti-inflammatory drugs at the molecular level. Eurasian J Med. 2018;50(2):116–121. doi:10.5152/eurasianjmed.2018.0010
   PubMed Web of Science ®Google Scholar
• Van Hecken A, Schwartz JI, Depre M, et al. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers. J Clin Pharmacol. 2000;40(10):1109–1120.
   PubMed Web of Science ®Google Scholar
• Derry S, Conaghan P, Da Silva JA, Wiffen PJ, Moore RA. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2016;4:Cd007400.
   PubMed Web of Science ®Google Scholar
• Zacher J, Altman R, Bellamy N, et al. Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin. 2008;24(4):925–950. doi:10.1185/030079908X273066
   PubMed Web of Science ®Google Scholar
• McGettigan P, Henry D, Strom BL. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011;8(9):e1001098. doi:10.1371/journal.pmed.1001098
   PubMed Web of Science ®Google Scholar
• Salvo F, Fourrier-Reglat A, Bazin F, et al. Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials. Clin Pharmacol Ther. 2011;89(6):855–866. doi:10.1038/clpt.2011.45
   PubMed Web of Science ®Google Scholar
• Brater DC. Anti-inflammatory agents and renal function. Semin Arthritis Rheum. 2002;32(3 Suppl 1):33–42. doi:10.1053/sarh.2002.37216
   PubMed Web of Science ®Google Scholar
• Altman R, Bosch B, Brune K, Patrignani P, Young C. Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology. Drugs. 2015;75(8):859–877.
   PubMed Web of Science ®Google Scholar
• Evans JM, McMahon AD, McGilchrist MM, et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ. 1995;311(6996):22–26. doi:10.1136/bmj.311.6996.22
   PubMed Web of Science ®Google Scholar
• Tiso RL, Tong-Ngork S, Fredlund KL. Oral versus topical Ibuprofen for chronic knee pain: a prospective randomized pilot study. Pain Physician. 2010;13(5):457–467.
   PubMed Web of Science ®Google Scholar
• Cordero JA, Alarcon L, Escribano E, Obach R, Domenech J. A comparative study of the transdermal penetration of a series of nonsteroidal antiinflammatory drugs. J Pharm Sci. 1997;86(4):503–508. doi:10.1021/js950346l
   Web of Science ®Google Scholar
• Cordero JA, Camacho M, Obach R, Domenech J, Vila L. In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs. Eur J Pharm Biopharm. 2001;51(2):135–142. doi:10.1016/S0939-6411(00)00149-1
   PubMed Web of Science ®Google Scholar
• Goh CF, Lane ME. Formulation of diclofenac for dermal delivery. Int J Pharm. 2014;473(1–2):607–616. doi:10.1016/j.ijpharm.2014.07.052
   PubMed Web of Science ®Google Scholar
• Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs. 2000;60(3):555–574. doi:10.2165/00003495-200060030-00004
   PubMed Web of Science ®Google Scholar
• Hadgraft J, Whitefield M, Rosher PH. Skin penetration of topical formulations of ibuprofen 5%: an in vitro comparative study. Skin Pharmacol Appl Skin Physiol. 2003;16(3):137–142. doi:10.1159/000069759
   PubMedGoogle Scholar
• Hagen M, Baker M. Skin penetration and tissue permeation after topical administration of diclofenac. Curr Med Res Opin. 2017;33(9):1623–1634. doi:10.1080/03007995.2017.1352497
   PubMed Web of Science ®Google Scholar
• OECD. Guidance Notes on Dermal Absorption. 2019.
   Google Scholar
• OECD. OECD Guidelines for the Testing of Chemicals: Skin Absorption: In vitro Method. 2004.
   Google Scholar
• Williams AC, Cornwell PA, Barry BW. On the non-gaussian distribution of human skin permeabilities. Int J Pharm. 1992;86(1):69–77. doi:10.1016/0378-5173(92)90032-W
   Web of Science ®Google Scholar
• Ema CHMP. Draft Guideline on Quality and Equivalence of Topical Products. 2018.
   Google Scholar
• Esser R, Berry C, Du Z, et al. Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. Br J Pharmacol. 2005;144(4):538–550. doi:10.1038/sj.bjp.0706078
   Web of Science ®Google Scholar
• Fini A, Laus M, Orienti I, Zecchi V. Dissolution and partition thermodynamic functions of some nonsteroidal anti-inflammatory drugs. J Pharm Sci. 1986;75(1):23–25. doi:10.1002/jps.2600750106
   Web of Science ®Google Scholar
• Brown MB, Martin GP, Jones SA, Akomeah FK. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 2006;13(3):175–187. doi:10.1080/10717540500455975
   PubMed Web of Science ®Google Scholar
• Lambers H, Piessens S, Bloem A, Pronk H, Finkel P. Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int J Cosmet Sci. 2006;28(5):359–370. doi:10.1111/j.1467-2494.2006.00344.x
   PubMedGoogle Scholar
• Sengupta C. Diclofenac sodium. In: Anti-Inflammatory and Anti-Rheumatic Drugs, Volume II: Newer Anti-Inflammatory Drugs. Boca Raton, FL: CRC Press; 1985:49–63.
   Google Scholar
• Pradal J, Vallet CM, Frappin G, Bariguian F, Lombardi MS. Importance of the formulation in the skin delivery of topical diclofenac: not all topical diclofenac formulations are the same. J Pain Res. 2019;12:1149–1154. doi:10.2147/JPR.S191300
   Web of Science ®Google Scholar
• O’Connor KM, Corrigan OI. Comparison of the physicochemical properties of the N-(2-hydroxyethyl) pyrrolidine, diethylamine and sodium salt forms of diclofenac. Int J Pharm. 2001;222(2):281–293. doi:10.1016/S0378-5173(01)00717-7
   PubMed Web of Science ®Google Scholar
• Khullar R, Kumar D, Seth N, Saini S. Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi Pharm J. 2012;20(1):63–67. doi:10.1016/j.jsps.2011.08.001
   PubMed Web of Science ®Google Scholar
• Stahl J, Wohlert M, Kietzmann M. The effect of formulation vehicles on the in vitro percutaneous permeation of ibuprofen. BMC Pharmacol. 2011;11(1):12. doi:10.1186/1471-2210-11-12
   Google Scholar
• Kim MJ, Doh HJ, Choi MK, et al. Skin permeation enhancement of diclofenac by fatty acids. Drug Deliv. 2008;15(6):373–379. doi:10.1080/10717540802006898
   PubMed Web of Science ®Google Scholar
• Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010;26(7):1715–1731. doi:10.1185/03007995.2010.486301
   PubMed Web of Science ®Google Scholar